Protective Effect of on Doxorubicin-induced Cytotoxicity in H9c2 Cardiomyoblast Cells.

Doxorubicin (DOX) is an effective anticancer drug. But its clinical application is limited, because DOX induces apoptosis in cardiomyocytes and it leads to permanent degenerative cardiomyopathy and heart failure. Recent trainings showed that exhibit pharmacological actions such as potent antioxidant. So, in this study we explored the protective effect of extract on doxorubicin-induced cytotoxicity in H9c2 cells. Cell viability was quantified by MTT assay. Apoptotic cells were determined using PI staining of DNA fragmentation by flowcytometry (sub-G1 peak). Cells were cultured with 5 μM DOX for 24 h to create the cell damage. H9c2 cells were pretreated with different concentrations (7.81-500 μg/mL) of extract (HSE) for 2 h before DOX treatment in all trials. Pretreatment with HSE increased cell viability at concentration of 31.25-500 μg/mL. Compared to control cells, apoptosis was induced in DOX treated cells after 24 h, (𝑃< 0.001). Pretreatment with HSE significantly decreased cell apoptosis after 24 hr at concentration of 31.25-250 μg/mL. Our results show that could exert the cardioprotective effects on DOX-induced toxicity partly by antiapoptotic activity.